Package 0078-0682-66

{"route": ["ORAL"], "spl_id": "27e1701b-e920-49fc-a56f-46b2d23a8271", "openfda": {"unii": ["B6DC89I63E"], "rxcui": ["1424916", "1424918", "1425228", "1425230", "2632552", "2632556"], "spl_set_id": ["fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (0078-0682-66)", "package_ndc": "0078-0682-66", "marketing_start_date": "20160412"}], "brand_name": "Tafinlar", "product_id": "0078-0682_27e1701b-e920-49fc-a56f-46b2d23a8271", "dosage_form": "CAPSULE", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Kinase Inhibitor [EPC]", "Organic Anion Transporter 1 Inhibitors [MoA]", "Organic Anion Transporter 3 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "0078-0682", "generic_name": "dabrafenib", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tafinlar", "active_ingredients": [{"name": "DABRAFENIB MESYLATE", "strength": "50 mg/1"}], "application_number": "NDA202806", "marketing_category": "NDA", "marketing_start_date": "20160412", "listing_expiration_date": "20261231"}